Literature DB >> 1720306

Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A.

P F Zipfel1, A Bialonski, C Skerka.   

Abstract

Human members of a family of structurally related cytokines, which play a role as effectors of inflammation, were analyzed for their expression and regulation in T lymphocytes. Members of this gene family include Platelet Basic Protein (PBP); Platelet Factor 4 (PF-4); IL-8/NAP-1; IP-10, a gamma interferon induced protein; GRO; pAT 464 and pAT 744. In resting T lymphocytes the RNAs of the individual genes could not be detected, but all genes were induced upon stimulation with PHA or with PHA/PMA. The induction of five genes was blocked by the immunosuppresive drug cyclosporin A (CSA), which appears to affect initial events in T cell activation. This expression in T lymphocytes, especially the sensitivity to CSA, indicates a common immunmodulatory role of these structural related proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720306     DOI: 10.1016/s0006-291x(05)81398-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.

Authors:  W Gao; P S Topham; J A King; S T Smiley; V Csizmadia; B Lu; C J Gerard; W W Hancock
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

2.  Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29).

Authors:  O Saitoh; R Matsuse; K Sugi; K Nakagawa; K Uchida; K Maemura; K Kojima; I Hirata; K Katsu
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Interleukin-8 is a cyclosporin A binding protein.

Authors:  H Bang; K Brune; C Nager; U Feige
Journal:  Experientia       Date:  1993-07-05

4.  Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis.

Authors:  C Bustos; S González-Cuadrado; M Ruiz-Ortega; C Gómez-Guerrero; E González; J J Plaza; J Egido
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

5.  Interleukin 8: cells of origin in inflammatory bowel disease.

Authors:  M C Grimm; S K Elsbury; P Pavli; W F Doe
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

6.  CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.

Authors:  Nicholas K Arger; Melissa E Ho; Isabel E Allen; Bryan S Benn; Prescott G Woodruff; Laura L Koth
Journal:  Respir Med       Date:  2019-11-20       Impact factor: 3.415

7.  Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A.

Authors:  H W Mages; R Baag; B Steiner; R A Kroczek
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

8.  IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy.

Authors:  B H Lemster; P B Carroll; H R Rilo; N Johnson; A Nikaein; A W Thomson
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

9.  Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome.

Authors:  T J Neuhaus; M Wadhwa; R Callard; T M Barratt
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

10.  Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes.

Authors:  C R Gattass; L B King; A D Luster; J D Ashwell
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.